BioStem Technologies

About BioStem Technologies

BioStem Technologies is a leading innovator in the development, manufacture, and commercialization of perinatal tissue-based allografts for regenerative therapies. Their mission is to improve patients' quality of life through scientific innovation and strict adherence to quality standards, utilizing their proprietary BioREtain® processing method to preserve the biological properties of fresh perinatal tissue.

Products & Services

VENDAJE®:A perinatal tissue-based allograft product for wound care.

VENDAJE AC®:An advanced version of the VENDAJE allograft for wound care applications.

VENDAJE OPTIC®:A specialized allograft product likely for optical or specific wound care needs.

AmnioWrap2:A perinatal tissue allograft designed for wound care and regenerative therapies.

Specialties

Perinatal tissue-based allografts Regenerative therapies Advanced wound care BioREtain® processing method

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 2000000 MR: - FA: $2 million FAN: 2000000	D: 2023-11-03 FD: 2023-11-03	-

Private Placement Latest

2023-11-03

$2.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jason Matuszewski

Chief Executive Officer / Chairman of the Board

LinkedIn (Pro only)

A

Andrew Van Vurst, CTBS

Chief Operating Officer

LinkedIn (Pro only)

B

Brandon Poe

Chairman of Audit Committee and Board Member

LinkedIn (Pro only)

B

Barry Hassett

Sr. Vice President of Commercial Strategy

D

Dr. Wendy W. Weston, PhD, CTBS

Vice President of Research and Development

M

Morgan Kim

Senior Vice President, Legal and Corporate Compliance

View 10 more team members with Pro

Unlock Full Team Directory

Recent News